Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
PharmaCyte Biotech ( (PMCB) ) has issued an update.
On September 2, 2025, PharmaCyte Biotech, Inc. announced an increased investment of $3 million in TNF Pharmaceuticals to support TNF’s acquisition of a license with LightSolver, a company recognized for its innovative computing technology. This strategic move aims to leverage LightSolver’s technology in cryptocurrency mining and blockchain, potentially enhancing TNF’s market position and operational capabilities.
More about PharmaCyte Biotech
PharmaCyte Biotech, Inc. operates in the biotechnology industry, focusing on developing cellular therapies for cancer and diabetes. The company is well-capitalized with significant cash resources and is actively seeking to diversify its investment portfolio.
Average Trading Volume: 52,797
Technical Sentiment Signal: Sell
Current Market Cap: $6.35M
For an in-depth examination of PMCB stock, go to TipRanks’ Overview page.